DeMONSTRATE-TB Study in Ethiopia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

DeMONSTRATE-TB Study in Ethiopia — Stella

Recruiting

Back to Reducing Tuberculosis Incidence trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Ethiopia

Gedebe Hassassa woreda, West Arsi Zone, Ormoia Regional State

Boloso Bombe woreda, Wolayita Zone, South Ethiopia Regional State

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Management Sciences for Health

Collaborators

KNCV Tuberculosis Foundation

Enrollment target

~131,438 participants

Started

February 2023

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov